Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carinna Hockham

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|June 16, 2023
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney FailurePeter J Blankestijn, Robin W M Vernooij, Carinna Hockham, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.
Trials|August 29, 2021
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trialCarinna Hockham, Sradha Kotwal, Arlen Wilcox, et al.
BMJ (Clinical Research Ed.)|November 17, 2022
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trialMeg J Jardine, Sradha S Kotwal, Abhinav Bassi, et al.
Plos One|September 6, 2024
Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trialsPatrizia Natale, Suetonia C Green, Matthias Rose, et al.
JMIR Research Protocols|April 15, 2020
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort StudyCeline Foote, Carinna Hockham, Louisa Sukkar, et al.
Journal of Clinical & Translational Endocrinology|December 9, 2020
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected dataHongmei Zhang, Kris Rogers, Louisa Sukkar, et al.
Journal of Diabetes Research|June 9, 2022
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE TrialTamara K Young, Nigel D Toussaint, Gian Luca Di Tanna, et al.
Diabetes, Obesity & Metabolism|May 10, 2023
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trialsAmy Kang, Brendan Smyth, Brendon L Neuen, et al.
Plos One|September 15, 2025
Correction: Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trialsPatrizia Natale, Suetonia C Green, Matthias Rose, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|June 16, 2023
Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney FailurePeter J Blankestijn, Robin W M Vernooij, Carinna Hockham, et al.
Diabetes, Obesity & Metabolism|May 19, 2022
Canagliflozin and atrial fibrillation in type 2 diabetes mellitus: A secondary analysis from the CANVAS Program and CREDENCE trial and meta-analysisChao Li, Jie Yu, Carinna Hockham, et al.
Trials|August 29, 2021
Protocol for the Controlled evaLuation of Angiotensin Receptor blockers for COVID-19 respIraTorY disease (CLARITY): a randomised controlled trialCarinna Hockham, Sradha Kotwal, Arlen Wilcox, et al.
BMJ (Clinical Research Ed.)|November 17, 2022
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trialMeg J Jardine, Sradha S Kotwal, Abhinav Bassi, et al.
Plos One|September 6, 2024
Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trialsPatrizia Natale, Suetonia C Green, Matthias Rose, et al.
JMIR Research Protocols|April 15, 2020
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort StudyCeline Foote, Carinna Hockham, Louisa Sukkar, et al.
Journal of Clinical & Translational Endocrinology|December 9, 2020
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected dataHongmei Zhang, Kris Rogers, Louisa Sukkar, et al.
Journal of Diabetes Research|June 9, 2022
Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE TrialTamara K Young, Nigel D Toussaint, Gian Luca Di Tanna, et al.
Diabetes, Obesity & Metabolism|May 10, 2023
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trialsAmy Kang, Brendan Smyth, Brendon L Neuen, et al.
Plos One|September 15, 2025
Correction: Frequent hemodialysis versus standard hemodialysis for people with kidney failure: Systematic review and meta-analysis of randomized controlled trialsPatrizia Natale, Suetonia C Green, Matthias Rose, et al.
Pageof 4